Table 1

Patient demographics in unmatched and propensity score-matched groups

Unmatched groupPropensity-matched group
Control (n=2101)High-dose methyl-prednisolone
(n=824)
p ValueControl (n=812)High-dose methyl-prednisolone
(n=812)
p Value
Sex (males, n (%))1570 (74.7)645 (78.3)0.044650 (80.0)634 (78.1)0.329
Age (years, n (%))
 ≤59786 (37.4)318 (38.6)0.022292 (36.0)313 (38.5)0.674
 60–69513 (24.4)219 (26.6)218 (26.8)216 (26.6)
 70–79456 (21.7)198 (24.0)213 (26.2)195 (24.0)
 ≥80346 (16.5)89 (10.5)89 (11.0)88 (10.8)
Charlson Comorbidity Index (n (%))
 11414 (67.3)456 (55.3)<0.001464 (57.1)456 (56.2)0.638
 2508 (24.2)287 (34.8)279 (34.4)276 (34.0)
 ≥3179 (8.5)81 (9.8)69 (8.5)80 (9.9)
Japan Coma Scale at admission (n (%))
 0 (alert)1811 (86.2)689 (83.6)0.085692 (85.2)681 (83.9)0.622
 1–3 (drowsy)200 (9.5)99 (12.0)95 (11.7)97 (11.9)
 10–30 (somnolence)36 (1.7)20 (2.4)15 (1.8)18 (2.2)
 100–300 (coma)54 (2.6)16 (1.9)10 (1.2)16 (2.0)
Cervical spinal surgery221 (10.5)189 (22.9)<0.001192 (23.6)178 (21.9)0.408
Preoperative length of stay (days, median (IQR))8 (1–17)8 (1–18)0.8388 (2–18)8 (1–17)0.683
Use of tracheostomy55 (2.6)51 (6.2)<0.00138 (4.7)48 (5.9)0.268
Hospital volume (per year, median (IQR))7 (4–12)8 (4–13)0.0047 (4–13)7.5 (4–13)0.188